ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wee, Boyoung ^a,b   Pietras, Alexander ^c,d,e   Ozawa, Tatsuya ^c,d   Bazzoli, Elena ^f   Podlaha, Ondrej ^g,h   Antczak, Christophe ^i,k   Westermark, Bengt ^j   Nelander, Sven ^j   Uhrbom, Lene ^j   Forsberg Nilsson, Karin ^j   Djaballah, Hakim ⁱ   Michor, Franziska ^g,h   Holland, Eric C ^c,d  

^a Cancer Biology and Genetics Program   (United States)

^b Brain Tumor Center   (United States)

^c USA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e LUND UNIVERSITY   (Sweden)

^f IRCCS   (Italy)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j UPPSALA UNIVERSITY   (Sweden)

^k NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCG2 PROTEIN, HUMAN; BREAST CANCER RESISTANCE PROTEIN; NOTCH RECEPTOR; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL; BRAIN TUMOR; CANCER STEM CELL; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HUMAN; METABOLISM; MOUSE; PATHOLOGY; RADIATION RESPONSE; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

ANIMALS; ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 2; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84979626532     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25956     Document Type: Article

References (28)

1. Pietras, A. Cancer stem cells in tumor heterogeneity. Adv Cancer Res 112, 255-281, doi: 10.1016/B978-0-12-387688-1.00009-0 (2011).
2. Pattabiraman, D. R. & Weinberg, R. A. Tackling the cancer stem cells-what challenges do they pose? Nat Rev Drug Discov 13, 497-512, doi: 10.1038/nrd4253 (2014).
3. Singh, S. K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 63, 5821-5828 (2003).
4. Anido, J. et al. TGF-beta Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell 18, 655-668, doi: 10.1016/j.ccr.2010.10.023 (2010).
5. Huse, J. T. & Holland, E. C. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10, 319-331, doi: 10.1038/nrc2818 (2010).
6. Pietras, A. et al. Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth. Cell stem cell 14, 357-369, doi: 10.1016/j.stem.2014.01.005 (2014).
7. Bleau, A. M. et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell stem cell 4, 226-235, doi: 10.1016/j.stem.2009.01.007 (2009).
8. Zhou, S. et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7, 1028-1034, doi: 10.1038/nm0901-1028 (2001).
9. Balbuena, J. et al. ABCG2 is required to control the sonic hedgehog pathway in side population cells with stem-like properties. Cytometry A 79, 672-683, doi: 10.1002/cyto.a.21103 (2011).
10. Susanto, J. et al. Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells. PloS one 3, e4023, doi: 10.1371/journal.pone.0004023 (2008).
11. Xie, Y. et al. The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes. EBioMedicine 2, 1351-1363, doi: 10.1016/j.ebiom.2015.08.026 (2015).
12. Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J immunol methods 347, 70-78, doi: 10.1016/j.jim.2009.06.008 (2009).
13. Patrawala, L. et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65, 6207-6219, doi: 10.1158/0008-5472.CAN-05-0592 (2005).
14. Bhattacharya, S., Das, A., Mallya, K. & Ahmad, I. Maintenance of retinal stem cells by Abcg2 is regulated by notch signaling. J Cell Sci 120, 2652-2662, doi: 10.1242/jcs.008417 (2007).
15. Pierfelice, T. J., Schreck, K. C., Eberhart, C. G. & Gaiano, N. Notch, neural stem cells, and brain tumors. Cold Spring Harb Symp Quant Biol 73, 367-375, doi: 10.1101/sqb.2008.73.013 (2008).
16. Bazzoli, E. et al. MEF promotes stemness in the pathogenesis of gliomas. Cell stem cell 11, 836-844, doi: 10.1016/j.stem.2012.09.012 (2012).
17. Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522-526, doi: 10.1038/nature11287 (2012).
18. Alonso, M. M. et al. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One 6, e26740, doi: 10.1371/journal.pone.0026740 (2011).
19. Nam, H. S. & Benezra, R. High levels of Id1 expression define B1 type adult neural stem cells. Cell Stem Cell 5, 515-526, doi: 10.1016/j.stem.2009.08.017 (2009).
20. Holmberg, J. et al. Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma. PLoS One 6, e18454, doi: 10.1371/journal.pone.0018454 (2011).
21. Charles, N. et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6, 141-152, doi: 10.1016/j.stem.2010.01.001 (2010).
22. Fan, X. et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28, 5-16, doi: 10.1002/stem.254 (2010).
23. Golebiewska, A. et al. Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Brain 136, 1462-1475, doi: 10.1093/brain/awt025 (2013).
24. Barrett, L. E. et al. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell 21, 11-24, doi: 10.1016/j.ccr.2011.11.025 (2012).
25. Holland, E. C. et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25, 55-57, doi: 10.1038/75596 (2000).
26. Hu, X. et al. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7, 356-368 (2005).
27. Ramirez, C. N. et al. Validation of a high-content screening assay using whole-well imaging of transformed phenotypes. Assay Drug Dev Technol 9, 247-261, doi: 10.1089/adt.2010.0342 (2011).
28. Antczak, C. et al. Domain-based biosensor assay to screen for epidermal growth factor receptor modulators in live cells. Assay Drug Dev Technol 10, 24-36, doi: 10.1089/adt.2011.423 (2012).